Efficacy of meropenem against ceftazidime–avibactam-resistant <i>Klebsiella pneumoniae</i> producing KPC-31, KPC-33, KPC-90, KPC-106 and KPC-114
These pre-clinical results might support use of meropenem as a potential alternative for treatment of infections due to KPC-variant producers displaying in vitro susceptibility to meropenem.
Authors
- Johana Becerra (ORCID: https://orcid.org/0000-0002-9813-1556)
- Jorge Luiz Mello Sampaio (ORCID: https://orcid.org/0000-0001-7789-3028)
- Felipe Vásquez‐Ponce (ORCID: https://orcid.org/0000-0002-9447-8325)
- Nilton Lincopán (ORCID: https://orcid.org/0000-0003-0161-5800)
- Gustavo Fernandes Queiroga Moraes (ORCID: https://orcid.org/0000-0001-7359-3095)
- Rubens Renato de Sousa Carmo (ORCID: https://orcid.org/0000-0001-7135-7531)
- Jesus G M Pariona (ORCID: https://orcid.org/0000-0001-9174-0749)
- Eva M. M. Pariona (ORCID: https://orcid.org/0000-0001-9026-8366)
- Aline Valério de Lima (ORCID: https://orcid.org/0000-0001-6325-1446)
- Thais Martins-Gonçalves (ORCID: https://orcid.org/0000-0003-4320-3089)
Institutions
- Universidade de São Paulo (BR)
- Universidad Peruana Cayetano Heredia (PE)
- Institute of Biomedical Science (GB)
Publication Details
- Journal
- Journal of Antimicrobial Chemotherapy
- Published
- 2024-10-28
- DOI
- https://doi.org/10.1093/jac/dkae389
- Citations
- 1
- Primary Topic
- Antibiotic Resistance in Bacteria
- Type
- article
- Field-Weighted Citation Impact
- 0.17
Funders
- Conselho Nacional de Desenvolvimento Científico e Tecnológico